Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 3
2006 3
2007 4
2008 1
2011 1
2012 2
2013 1
2017 1
2018 2
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Modifier genes and sickle cell anemia.
Steinberg MH, Adewoye AH. Steinberg MH, et al. Among authors: adewoye ah. Curr Opin Hematol. 2006 May;13(3):131-6. doi: 10.1097/01.moh.0000219656.50291.73. Curr Opin Hematol. 2006. PMID: 16567954 Review.
Hemoglobin SE disease: a concise review.
Masiello D, Heeney MM, Adewoye AH, Eung SH, Luo HY, Steinberg MH, Chui DH. Masiello D, et al. Among authors: adewoye ah. Am J Hematol. 2007 Jul;82(7):643-9. doi: 10.1002/ajh.20847. Am J Hematol. 2007. PMID: 17278112 Free article. Review.
Chaperones and disease.
Adewoye AH, McMahon L. Adewoye AH, et al. N Engl J Med. 2005 Dec 29;353(26):2821-2; author reply 2821-2. doi: 10.1056/NEJMc052995. N Engl J Med. 2005. PMID: 16382075 No abstract available.
Two new alpha-thalassemia frameshift mutations.
Luo HY, Adewoye AH, Pilichowska M, Li MY, Basran RK, Steinberg MH, Chui DH. Luo HY, et al. Among authors: adewoye ah. Hemoglobin. 2007;31(2):135-9. doi: 10.1080/03630260701285118. Hemoglobin. 2007. PMID: 17486494
Final results of a phase 1b study of the safety and efficacy of the PI3Kδ inhibitor acalisib (GS-9820) in relapsed/refractory lymphoid malignancies.
Kater AP, Tonino SH, Spiering M, Chamuleau MED, Liu R, Adewoye AH, Gao J, Dreiling L, Xin Y, Doorduijn JK, Kersten MJ; HOVON Lunenburg Lymphoma Phase I/II Consortium. Kater AP, et al. Among authors: adewoye ah. Blood Cancer J. 2018 Feb 12;8(2):16. doi: 10.1038/s41408-018-0055-x. Blood Cancer J. 2018. PMID: 29434192 Free PMC article. Clinical Trial. No abstract available.
Sickle cell bone disease: response to vitamin D and calcium.
Adewoye AH, Chen TC, Ma Q, McMahon L, Mathieu J, Malabanan A, Steinberg MH, Holick MF. Adewoye AH, et al. Am J Hematol. 2008 Apr;83(4):271-4. doi: 10.1002/ajh.21085. Am J Hematol. 2008. PMID: 17924548 Free article. Clinical Trial.
Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial.
Zelenetz AD, Barrientos JC, Brown JR, Coiffier B, Delgado J, Egyed M, Ghia P, Illés Á, Jurczak W, Marlton P, Montillo M, Morschhauser F, Pristupa AS, Robak T, Sharman JP, Simpson D, Smolej L, Tausch E, Adewoye AH, Dreiling LK, Kim Y, Stilgenbauer S, Hillmen P. Zelenetz AD, et al. Among authors: adewoye ah. Lancet Oncol. 2017 Mar;18(3):297-311. doi: 10.1016/S1470-2045(16)30671-4. Epub 2017 Jan 28. Lancet Oncol. 2017. PMID: 28139405 Free PMC article. Clinical Trial.
Lacrimal gland enlargement in sickle cell disease.
Adewoye AH, Ramsey J, McMahon L, Sakai O, Steinberg MH. Adewoye AH, et al. Am J Hematol. 2006 Nov;81(11):888-9. doi: 10.1002/ajh.20658. Am J Hematol. 2006. PMID: 16929543 Free article.
18 results